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Nutrition and maternal morbidity and mortality
Andrew Tomkins
Centre for International Child Health, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK
Nearly 600 000 women die every year from pregnancy related conditions and the maternal
mortality rates (MMR  deaths per 100 000 live births) in developing countries may be as high
as 1000 compared with less than ten in industrialised countries. In the light of the striking impact
of deficiencies of micronutrients such as vitamin A and zinc on immune function, morbidity and
mortality in children it seems reasonable to suggest that such deficiencies might play a
contributing role in the high rates of morbidity and mortality in mothers. Hitherto, there has
been rather little published on the contribution of malnutrition to maternal morbidity or
mortality but recent results of micronutrient supplementation show a major effect of vitamin
A or beta carotene supplementation on maternal mortality in Nepal and an impressive effect of a
multiple micronutrient mixture on pregnancy outcome in Tanzania. There is now data showing
that subclinical mastitis, a potential risk factor for mother to child transmission of HIV by
increasing levels of virus in breast milk, is influenced by maternal diet in Tanzania and feeding
patterns in South Africa. Considering the massive tragedy of maternal mortality the recent data
provides opportunities for new, innovative nutritional interventions for the reduction of the
global burden of maternal morbidity and mortality.
Infection: Pregnancy: Illness: Micronutrients: Human Immunodeficiency Virus:
Vitamin A
Measurement issues and trends
Maternal mortality rates (MMR) are calculated as deaths
per 100 000 births, extending from 28 weeks of pregnancy
to 6 weeks postpartum. Where there is vital registration
with accurate recording of births and deaths it is possible to
make assessments of secular changes in MMR and to
compare such changes with specific interventions. Unfor-
tunately, most developing countries do not have vital
registration and alternative techniques have to be used
including indirect interview methods such as the ‘sister-
hood’ method where women are interviewed about the
occurrence of a pregnancy-related death in the family.
There are advantages and disadvantages of all these
techniques, the greatest problem being under-reporting. A
comparison of MMR using three data sources was
performed in Matlab, Bangladesh (Ronsmans et al. 1998).
The investigators compared maternal deaths identified
through a unique demographic surveillance system (DSS),
using a previous detailed investigation into the levels and
causes of maternal mortality, and deaths identified in a
special study of lay reporting. There were important and
substantial disagreements between the routine reporting
and the special studies, and up to 50 % differences in MMR
using the different approaches. This has important
implications for any monitoring or evaluation of pro-
grammes aimed at reducing MMR (Ronsmans et al. 1997).
Thus randomised controlled clinical trials with rigorous
recording of demographic indices are especially important
in establishing the evidence base for nutritional interven-
tions aimed at reducing maternal morbidity and mortality.
Globally, around 600 000 women die every year from
pregnancy related causes. Many of these women are short,
thin, and anaemic and have a variety of micronutrient
deficiencies. Malnutrition is associated with increased risk
of morbidity and mortality in children; even allowing for
the confounding socio-economic factors which caused
them to be malnourished in the first place (Tomkins &
Watson, 1989). Similarly the low anthropometric scores
and micronutrient deficiencies are associated with impaired
function of different aspect of the immune response
(Waterlow et al. 1992). Thus it is strongly intuitive to
conclude that malnutrition contributes to the high rates of
maternal morbidity and mortality in developing countries
but it is only recently that randomised controlled clinical
trials of the effect of nutrition interventions on maternal
morbidity and mortality have been published (West et al.
1999) (Fawzi et al. 1998).
Prior to these there have been rather negative reviews on
the role of nutrition, drawing on limited secular analyses of
the changes in maternal mortality in the UK (Loudon,
1992; Loudon, 2000). MMR at the beginning of the
nineteenth century was around 1000 – higher than in most
countries today; it fell gradually over the following decades
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but was still high until the mid-1930s. Several major
concurrent changes were noted including improved stan-
dards of care at delivery, a reduction in the virulence of
Streptococcus pyogenes, the availability of antibiotics, such
as sulphonamides and penicillin, the widespread use of
ergometrine to reduce postpartum haemorrhage, increased
use of blood transfusion and better training and facilities for
good obstetric practice (Loudon, 1987). Many of these are
still not widely available in developing countries and the
nutritional status of women in many developing countries is
far worse than in Europe, even in the nineteenth century.
Recent reviews of the possible interventions to prevent
mortality from induced abortion, puerperal infection and
pregnancy induced hypertension suggested that there is
insufficient evidence for an important role for nutrition
(Rush, 2000; Stein et al. 1978). They also suggest it may
not be beneficial, from the perspective of risk of obstructed
labour, to promote increased food intake during pregnancy.
However interpretation of the reasons for differences in
Caesarean section rates as an indicator of pelvic dispropor-
tion is fraught with difficulty because of the many factors
influencing whether to perform surgery or not. Overall,
despite the strongly argued concerns by Rush (Rush, 2000)
and Garner (Garner et al. 1992) there is little evidence of an
increased prevalence of obstructed labour among women
receiving dietary supplementation. Indeed in one of the
most careful studies of nutritional supplementation and
pregnancy outcome, in the Gambia, there was no evidence
of increased obstetric complications even though birth
weight increased significantly (Ceesay et al. 1997). In
addition there was clear evidence of a reduction in perinatal
mortality rate. There has, until recently, been insufficient
information on whether there is a separate impact, in terms
of pregnancy outcome, of improvement in micronutrient
status as distinct from an overall improvement in
anthropometric indices.
A review of data from Bangladesh (Goodburn et al.
1995) and a global review (Liskin, 1992) conclude that
maternal morbidities appear to occur frequently but very
little is known about their magnitude or causes. Goodburn
et al. (1995) points out that women’s beliefs about disease
causation have profound importance on the way that they
live, seek treatment and feel. In the absence of studies
which have carefully compared symptoms with more
rigorous indices of inflammation (Darling et al. 1999), it
has been difficult to conclude much about the prevalence,
let alone the impact of nutrition on morbidity. The recent
data from Nepal are very instructive (Christian et al. 1998;
Christian et al. 2000a).
Descriptive studies of causes of maternal mortality
There are important differences in the cause of maternal
mortality between communities and countries; these may
well influence the degree of impact that nutritional
interventions may have. In Indonesia haemorrhage, infec-
tion and toxaemia of pregnancy accounted for 91 % of
deaths resulting in an MMR of 390 (Chi et al. 1981). In
Bloemfontein in South Africa, MMR was 720 with
puerperal sepsis and post-abortion sepsis accounting for
46 % of the deaths (Cooreman et al. 1989). An early study
from Zambia in the 1970s showed an MMR of 1500. The
commonest deaths in order of importance were toxaemia,
septicaemia, haemorrhage and ruptured uterus. At that
time, 32 % of women had received no antenatal care
(Hickey & Kasonde, 1977).
In the Gambia in the early 1990s, MMR, excluding non-
abortion causes, was 736 (Hoestermann et al. 1996).
Among the direct causes in order of importance, haemor-
rhage, toxaemia of pregnancy, sepsis and anaemia were all
major contributing causes to maternal mortality. A long-
itudinal study of a rural area in the Gambia in which there
have been intense nutritional and medical interventions
over a period of 10 years, showed remarkable reductions in
perinatal mortality (from 110 to 45), infant mortality (from
148 to 24), and mortality in the under 5s (from 109 to 13)
(Lamb et al. 1984). There were no pregnancy related
maternal deaths in this community over a period of 8 years,
during which time 16 would have been expected given
current estimates for MMR. The authors concluded that
nutrition interventions and the 24-hour availability of a
physician and/or qualified midwife were the reason why a
dramatic response had been achieved but they were not able
to dissect the relative importance of the nutritional
component of the intervention. A retrospective study
evaluating the particular problems of adolescent maternal
mortality, with very little intervention, was performed in
Burkina Faso showing that the adolescent MMR was 4081
– one of the highest MMR ever recorded; the most frequent
causes of death were abortion and chronic anaemia
(Lankoande et al. 1999). The importance of improved
care for the vulnerable pregnant teenager has been high-
lighted again recently (Brabin et al. 1998).
During a review of the community programmes in
Matlab, Bangladesh it was noted that obstetric related
deaths had declined strikingly in the intervention area
(where a package of mother and child health interventions
had been introduced) but not in the control area (Ronsmans
et al. 1997). This decline was attributed primarily to the
posting of midwives at the village level and the appoint-
ment of doctors at the local maternity clinics. The authors
suggested that these staff played a key role in improving
delivery services and providing early recognition of
obstetric problems and increasingly referred complex
cases to a local government hospital where Caesarean
sections and blood transfusions were available. There were
no specific nutrition interventions.
During a study of the impact of malaria control in
Mangochi in Southern Malawi, an MMR of 370 was
calculated but there was no report on whether malaria
control reduced the prevalence of maternal morbidity
(McDermott et al. 1996). A randomised control trial of
the impact of frequent versus infrequent home visiting by
midwives to women who had recently delivered in Zambia,
demonstrated interesting findings in relation to morbidity
(Ransjo-Arvidson et al. 1998). Those visited more
frequently, visited health centres more frequently for
illnesses in themselves or their infants, however details of
the maternal illnesses were not described. The sample was
too small to detect improved recognition and treatment of
postpartum complications.
A recent retrospective analysis of MMR in a hospital
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based study in Kwazulu Natal, South Africa showed an
overall MMR of 144, the main causes of death being
toxaemia of pregnancy and haemorrhage (Moodley et al.
1996). Less than half of the women who died attended an
antenatal clinic. There is no data on the MMR among those,
evidently the majority of women, who for one reason or
another did not attend a health facility for their delivery. An
MMR of below 100 was noted in Cape Town, possibly due
to the greater use of the obstetric ‘flying squad’ (van
Coeverden de Groot HA, 1979). Around half of the patients
who died had not received antenatal care. The commonest
causes of maternal death were, in order of priority,
toxaemia of pregnancy, haemorrhage, cardiac disease,
pulmonary embolism, sepsis, trauma and anaesthetic
complications. An analysis of hospital based maternal
mortality in Turkey showed an MMR of 822 (Ayhan et al.
1994). Seventy-seven per cent of the deaths were due to
direct obstetric causes including toxaemia, infection and
haemorrhage.
It appears that there is considerable heterogeneity in the
rates and causes, both direct and non-direct, of maternal
mortality. MMR may be relatively easy to measure given
support for a large population study but the difficulties in
assessing causes of mortality remain. This has implications
for assessing the reasons for any differential impact that
nutritional interventions may have.
Association between malnutrition and infection
Faisel & Pitroff (Faisel & Pittrof, 2000) have recently
reviewed the interaction between vitamin A and causes of
maternal mortality, emphasising the possible association
and biological plausibility. They indicate prospective
studies on women who had low vitamin A levels in the
blood during the second trimester of pregnancy and
throughout the postpartum period. These women had an
increased risk of puerperal infection. The recently pub-
lished Nepal vitamin A study also showed that pregnant
women with night blindness were twice as likely to develop
genito-urinary infections than women without night blind-
ness (Christian et al. 2000b). However, the impact of
systemic infection and metabolic stress on vitamin A is
well documented and in most of these studies it is almost
impossible to know which came first – either the metabolic
or infective stress or the low plasma vitamin A.
A detailed assessment of nutritional interventions for the
prevention of maternal morbidity was recently published
using a meta-analysis of the few randomised-controlled
trials (Kulier et al. 1998). Several studies show an
association between high levels of plasma ferritin in the
third trimester and very preterm delivery and clinical
infections, emphasising the effect of the inflammatory
response on markers that are traditionally used for
assessing micronutrient status (Goldenberg et al. 1996).
Ferritin is remarkable in its lability in response to infection
and other markers such as transferrin receptors have been
used more frequently. One of the most striking examples of
the interaction between inflammation and plasma/serum
levels of infection is the increase in ferritin levels in
pregnant women with a high prevalence of infection,
almost precluding the use of ferritin as an indicator of iron
status in pregnancy in certain populations. Recent studies
have examined the possible use of transferrin receptors as
better markers of iron status in inflammation. Their levels
are much less perturbed by inflammation than ferritin but
there are significant changes during episodes of malaria for
instance (Beesley et al. 2000). The role of iron deficiency
in contributing to the high rates of morbidity in pregnancy
is not established even though improving iron status as a
means to prevent the development of anaemia is usually
accepted.
While there is increasing recognition of the high
prevalence of intestinal helminths in pregnant women,
and an appreciation of the improved pregnancy outcome if
deworming is provided (de Silva et al. 1996; de Silva et al.
1999) there is little evidence on the role of nutrition in
increasing susceptibility to intestinal helminths. Limited
studies of micronutrients in relation to schistosomiasis in
Zimbabwe have identified a close association between
micronutrient deficiency, especially zinc, and schistoso-
miasis (Friis et al. 1996). The impact of zinc deficiency on
intestinal response to enteric pathogens is well recognised
(Roy et al. 1997), but a putative role for nutritional
deficiency in relation to increased susceptibility for gut
helminths in humans is not established. Iodine deficiency is
associated with increased rates of stillbirth, premature
delivery and spontaneous abortion. How much these
potentially dangerous conditions contribute to maternal
morbidity and mortality has not been studied though the
risks are evident (Hetzel, 1989; Delange, 2000).
Micronutrient interventions and maternal morbidity
and mortality
While there is virtually no data (using post-mortem
confirmation of clinical diagnosis) in developing countries
on the specific direct causes (i.e. those which are thought to
be the final cause of death) of maternal mortality, improved
clinical awareness and the use of verbal autopsy give some
clues.
A recent study in Nepal (West et al. 1999) shows a
remarkable reduction in maternal mortality as a result of
supplementation with beta carotene or vitamin A. A total of
44 646 married women, of whom 20 119 became pregnant
were included in the study. The women were randomised to
receive, weekly, a single oral supplement of placebo,
vitamin A (7000 mg RE) or b carotene (42 mg or 7000 RE)
for over 3·5 years. All causes of mortality in women during
pregnancy up to 12 weeks postpartum (pregnancy related
mortality) and mortality during pregnancy to 6 weeks
postpartum, excluding deaths apparently related to injury
(maternal mortality) were used as the main outcome
measures. Mortality related to pregnancy in the placebo,
vitamin A and b carotene groups was 704, 426 and 361
deaths per 100 000 pregnancies, giving relative risks of
0·60 and 0·51 among those who received vitamin A and b
carotene, respectively. Combined, vitamin A or b carotene
lowered mortality by 44 % and reduced the maternal
mortality rate ratio from 645 to 385 deaths per 100 000 live
births. Important causes of maternal mortality, in order of
frequency, were obstetric-related causes, eclampsia, hae-
morrhage, sepsis and injury. There was not sufficient
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statistical power to ascribe the mortality impact of vitamin
A or b carotene to their effect on one cause of mortality
rather than another. This important study is the only one
published to date describing the impact of a micronutrient
supplementation on maternal mortality. Others are under-
way; it will be especially interesting to know how much
micronutrients impact on maternal mortality in areas where
infections, such as malaria and HIV for example, are
common.
Within the framework of this large study an analysis of
the impact of these supplements on symptoms of illness
was performed (Christian et al. 2000a). There was no
impact of either supplement on morbidity rates reported up
to 28 weeks of gestation, inclusive. However in late
pregnancy (.28 weeks), symptoms of nausea, faintness
and night blindness were reduced with vitamin A, but not b
carotene supplementation. Vitamin A supplementation
shortened the length of labour by 1·5 h and 50 min
among nulliparous and multiparous women, respectively.
Both interventions reduced the postpartum prevalence of at
least four loose stools and night blindness. b Carotene
supplementation also reduced the number of episodes of
high fever postpartum. The mean number of days of any
reported illness symptoms was 3–4 per week throughout
pregnancy. Among women receiving vitamin A, the total
number of days of illness symptoms accrued over the last
12 weeks of pregnancy was lower by 5 days compared with
the placebo recipients. There are very few publications on
rates of morbidity among pregnant women and the above
study has the only data published to date describing the
impact of a micronutrient supplementation on morbidity.
Interestingly, there were earlier reports of the development
of diarrhoea and malabsorption syndromes associated with
pregnancy in South Africa (Jacobson, 1972; Moshal et al.
1973) and Singapore (Whitfield, 1967). These were
originally attributed to deficiency of folic acid, but it
seems possible that vitamin A deficiency might also have
played a role.
A study of 1075 HIV positive women in Dar es Salaam,
Tanzania examined the impact of vitamin A with or
without micronutrients (20 mg B1, 20 mg B2, 25 mg B6,
100 mg niacin, 50 mg B12, 500 mg vitamin C, 30 mg
vitamin E and 0·8 mg folic acid) on pregnancy outcome.
Women were recruited at between 12 and 27 weeks
gestation and received their regular supply of antenatal iron
and folic acid. They were randomised to receive placebo,
vitamin A, a mixture of multivitamins without vitamin A,
or a mixture of multivitamins including vitamin A. There
were 30 fetal deaths in the women receiving multivitamins
compared with 49 among those not receiving multi-
vitamins. The prevalence of low birth weight (,2500 g)
was 15·8 % in those receiving placebo and 8·8 % in those
receiving the multivitamins. The prevalence of severe
prematurity (,37 weeks) was 10·2 % in those receiving
placebo and 6·2 % in those receiving multiple micronu-
trients. Interestingly, vitamin A did not affect any of the
pregnancy related variables. Multivitamins, but not vitamin
A, resulted in an increase in CD4, CD8 and CD3 counts.
This is the only published study on the effect of
multivitamins on such outcomes to date.
A recent study of the impact of daily supplements of
vitamin A and zinc in preventing puerperal sepsis has been
conducted in Indonesia using body temperature as an
indicator of puerperal sepsis (Hakimi et al. 1999). Sepsis
was scored on the basis of a body temperature of .388C on
at least 1 of the 14 days postpartum that they were visited.
There was an elevated body temperature in only 2·8 % of
women receiving vitamin A, compared with 9·3 % of
women receiving placebo.
A review of the impact of vitamin A supplements as
‘anti-infective’ interventions (Semba, 1999) describes the
earlier work of supplementation with cod liver oil as a
protection against puerperal sepsis in the UK. Using
various criteria for puerperal sepsis there was a lower
incidence among women receiving cod liver oil than among
those who did not. In view of the recent interest in the
immunological effect of vitamin D (Wilkinson et al. 2000),
the high concentration of vitamin D in cod liver oil may
also have been important; it would be interesting to explore
this in future studies.
An acute phase metabolic response may be shown by
significantly higher levels of serum C-reactive proteins. A
study in Tanzania, which examined the impact of dietary
supplementation with sunflower seed oil which is rich in
tocopherols, showed that pregnant women receiving this oil
had lower acute phase protein levels in the postpartum
period compared with a control group of women (Filteau
et al. 1999). The sample size was too small to be able to
relate these changes to the clinical outcome but it raises the
possibility that improved antioxidant intake may reduce
maternal morbidity. Perhaps the changes in immunological
indices and pregnancy outcome observed among Tanzanian
women receiving multiple vitamin supplements is attribu-
table to the high dose of vitamin E in that study (Fawzi et
al. 1998). No data on the effect of antioxidants other than b
carotene on maternal morbidity have been reported so far.
In view of the considerable interest in the role of vitamin E
in the structure of the viral genome and the tissue response
to pathogens it seems that assessment of the impact of
vitamin E supplementation on infection in HIV subjects is
particularly important (Beck, 2000; Beck & Levander,
2000).
In recent studies among lactating women in several
developing countries the presence of subclinical mastitis
has been documented (Willumsen et al. 1999). This
condition involves an increase in permeability in the
capillary/mammary cell junction leading to an increase in
sodium content of the milk. Increased cytokine concentra-
tions are present and have a close correlation with Na/K
levels in breast milk, so close in fact that Na/K can be used
to monitor the inflammatory process. The precise biology
of this condition has not yet been identified but it has
considerable functional significance. Subclinical mastitis is
associated with higher levels of viral load in the breast milk
of HIV positive mothers. It is also associated with growth
faltering, presumably due to decreased breast milk produc-
tion. Two key factors have been identified recently as risk
factors for subclinical mastitis. First, the infant feeding
pattern; mothers who breast-feed exclusively have a lower
prevalence of subclinical mastitis compared with those who
use mixed feeding. Second, systemic infection; postpartum
sepsis and malaria are associated with increased Na/K
S96 A. Tomkins
levels which fall as the temperature responds to treatment.
Presumably the increased circulating cytokines from a
systemic infection increase the breast milk levels and
induce an increased sodium secretion. It is not yet clear
how common this condition is but published studies show
that sub clinical mastitis is present in a quarter of the
women studied in Bangladesh, Tanzania, Malawi and
South Africa (Willumsen et al. 2000).
Toxaemia of pregnancy
In a review of the possible links between nutrition and
toxaemia, numerous theories have been examined (Maine,
2000). Interestingly, somewhat like the MMR, there has
been remarkable reduction in the rates of toxaemia in some
populations over periods of time where nutrition has not
changed at all and vice versa. She concludes that there is no
available evidence to show a role of nutrition in reducing
rates of maternal mortality from toxaemia. Others conclude
that the relationships are there. There is considerable
interest in the pathology of the placenta in relation to pre-
eclampsia and toxaemia of pregnancy. Several studies have
examined the placental production of lipid peroxides;
Wang has shown that activities of copper and zinc
dependent enzymes and the tissue levels of vitamin A are
significantly lower in pre-eclamptic compared to normal
placentas (Wang & Walsh, 1996). The activity of catalyse
is significantly higher and it is speculated that decreased
antioxidant activity may result in increased lipid peroxide
levels in pre-eclamptic toxaemia leading to local pathology
and a cascade of immunological events leading to increased
blood pressure. Yanik examined the antioxidant status of
subjects with pre-eclampsia and eclampsia, comparing
them with normo-tensive pregnant women (Yanik et al.
1999). Both the pre-eclamptic and eclamptic patients had
higher levels of serum malondialdehyde and lower vitamin
E levels. Malondialdehyde levels were significantly
correlated with systolic and diastolic blood pressure,
suggesting that the imbalance between lipid peroxidation
and serum vitamin E levels is not only responsible for
abnormalities in the placenta but may have contributed to
hypertension.
Programme implications
Women in developing countries are frequently malnour-
ished and often have a poor pregnancy outcome. The new
data shows the close link between malnutrition and illness
or death during pregnancy and lactation. Until now, most
programmes on Safer Motherhood have paid little attention
to improving nutrition. Improving obstetric care is an
obviously crucial, but insufficient, step for safer mother-
hood. The current evidence suggests that improvement of
vitamin A status in the preconceptual and pregnancy
periods produces significant changes in mortality and some
decrease in morbidity. It is not yet known if supplementa-
tion starting in pregnancy is as effective. Moreover it is not
yet clear as to how much reduction in mortality could be
achieved by improving vitamin A status in a country where
antenatal, midwifery and obstetric care are better devel-
oped. There are also striking improvements in pregnancy
outcome as a result of a certain combination of
micronutrients. It is not known whether this is the optimal
combination of micronutrients or whether the improve-
ment in pregnancy outcome as a result of multiple
micronutrients given in pregnancy is the same among HIV
negative mothers. Neither is it known if such an effect
would be observed where malaria or tuberculosis is
common. Studies providing answers to these questions are
needed urgently.
From a programmatic perspective, there are many
interventions required to bring down the appallingly high
MMR in developing countries. Safer motherhood regimes
have traditionally focused on improving antenatal care
and delivery services together with improvement in
women’s status and life-style over the years. There
have been improvements in MMR in some countries as a
result of such programmes but MMR is still at
devastatingly high levels in many and even increasing
in some. There is now growing support for micronutrient
enhancement even though it is not yet possible to say
how much pregnancy related morbidity and mortality
will be influenced by nutritional interventions in different
situations. It is now possible to improve micronutrient
status of pregnant and lactating women (Huffman et al.
1998; Alnwick, 1998). Dietary diversification, food
fortification and supplementation are all possible and
there are different strategies for the short and long term
which take account of sustainability and affordability.
There is no place for a slavish doctrinaire approach
which claims that there is only one way of improving
nutrition of girls and women in order to prevent them
from becoming ill or dying in pregnancy. Those who
espouse one approach for the improvement of nutrition
while deprecating another need to acknowledge the new
and emerging evidence that lives can be saved as a result
of micronutrient supplements. Families, communities,
local authorities, national governments and international
agencies want to improve the nutritional status of
women. The challenge for nutritional researchers is to
provide information on the scale of the benefits in a
variety of situations using different interventions.
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